Mineral Forms · Mineral
Chromium Citrate
Preliminary EvidenceCompound
Hermetica Superfood Encyclopedia
Chromium citrate is a mineral supplement that combines elemental chromium with citric acid for enhanced bioavailability. The chromium content may support glucose metabolism by enhancing insulin sensitivity through improved glucose tolerance factor function.
Chromium citrate is a synthetic coordination compound formed by combining trivalent chromium (Cr(III)) with citric acid, appearing as a greenish or yellowish water-soluble powder. It is produced chemically rather than derived from natural sources, with the molecular formula C6H5CrO7 and molecular weight around 241.1 g/mol.
No human clinical trials, RCTs, or meta-analyses specific to chromium citrate were found in the available research. The evidence base consists only of general references to chromium's theoretical role in glucose metabolism without study designs, sample sizes, or outcome data for the citrate form.
No clinically studied dosage ranges have been established for chromium citrate. Consult a healthcare provider before starting any new supplement.
Chromium citrate is a mineral supplement providing trivalent chromium (Cr³⁺) chelated with citric acid. Key nutritional details: **Primary mineral:** Chromium (Cr³⁺), typically yielding approximately 200–1000 µg of elemental chromium per standard supplement dose, though common dosing is 200–500 µg/day. The chromium content by weight in chromium citrate is approximately 25–26% elemental chromium (molecular formula: Cr(C₆H₅O₇)·nH₂O or similar citrate complex, MW ~247–350 g/mol depending on hydration and stoichiometry). **Bioavailability:** Chromium citrate demonstrates moderately enhanced bioavailability compared to inorganic chromium salts (e.g., chromium chloride), estimated at 2–5% absorption rate — higher than chromium chloride (~0.4–2%) but generally lower than chromium picolinate (~2–5.2%). The citrate ligand improves solubility at physiological pH, facilitating intestinal absorption primarily in the jejunum via passive diffusion and possibly transferrin-mediated uptake. **Macronutrients:** Essentially zero calories, zero protein, zero fat, zero carbohydrates, and zero fiber — it is a pure mineral-organic acid chelate. **Citric acid component:** The citrate moiety (~74–75% by weight) provides negligible caloric or nutritional value at supplement doses. **No vitamins, fiber, or other bioactive compounds** are present unless formulated as part of a multi-ingredient supplement. **Adequate Intake (AI) reference:** The AI for chromium is 25 µg/day (women) and 35 µg/day (men) per the IOM (2001), though these values are considered provisional and based on limited data. **Interactions affecting bioavailability:** Absorption may be enhanced by co-administration with vitamin C (ascorbic acid) and reduced by concurrent intake of antacids, calcium carbonate, or high-phytate foods. Iron and zinc may compete for absorption pathways. Chromium is transported in the blood primarily bound to transferrin and stored in the liver, spleen, soft tissue, and bone. **Safety note:** Trivalent chromium (Cr³⁺) as found in chromium citrate has very low toxicity; no Tolerable Upper Intake Level (UL) has been established by the IOM due to insufficient adverse effect data, though supplements typically range from 200–1000 µg without reported toxicity in healthy individuals.
Chromium citrate provides elemental chromium that may enhance insulin receptor binding and improve glucose uptake in peripheral tissues. The chromium component potentially activates insulin receptor kinase activity and facilitates glucose transporter-4 (GLUT-4) translocation to cell membranes. The citrate chelation theoretically improves chromium absorption compared to inorganic forms.
No specific clinical trials have been conducted on chromium citrate as a distinct supplement form. Most chromium research focuses on picolinate forms or inorganic chromium chloride supplements. The theoretical benefits are extrapolated from general chromium research, which shows mixed results for glucose control with doses ranging from 200-1000 mcg daily. Evidence quality remains limited with small sample sizes and inconsistent methodologies across chromium studies.
Chromium citrate is generally well-tolerated at doses up to 200-400 mcg daily, with minimal reported side effects. Potential interactions may occur with antacids, proton pump inhibitors, and H2 blockers that could reduce chromium absorption. High doses exceeding 1000 mcg daily may cause gastrointestinal upset, headaches, or skin irritation. Safety during pregnancy and breastfeeding has not been established for chromium citrate specifically.
